Contipharma Belgium

To develop and market innovative medical solutions that address unresolved public health challenges, focusing our expertise on:

• R&D of next-generation non-invasive diagnostics;
• Improving access to essential medicines that are in short supply or unaffordable.

Firmly committed to innovation, our diagnostic solutions offer culturally acceptable and technologically advanced alternatives to conventional methods. They are specifically designed to meet the challenges of remote areas and the demands of epidemic emergencies.

Each of our solutions takes into account local realities in all their dimensions—economic, logistical, and cultural—ensuring products that are truly tailored to the needs of the populations concerned.

In line with the requirements of the World Health Organization (WHO), Contipharma relies on a network of leading scientific collaborations and works closely with internationally renowned research institutions, including the National Institute of Biomedical Research (INRB) in Kinshasa, the University of Liège in Belgium, and a network of recognized European industrial laboratories.